UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6576
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$103M
| $265K | ﹤0.01% |
5,163
+14
| +0.3% | +$718 |
2014 Q4
46 quarters
|
|
6577
PUT
Innodata
INOD
$1.27B
| $265K | ﹤0.01% |
+3,500
| New | +$257K |
2026 Q2
0 quarters
|
|
6578
CALL
Paycom
PAYC
$10.5B
| $264K | ﹤0.01% |
2,100
-69,000
| -97% | -$9M |
2025 Q1
5 quarters
|
|
6579
Guardforce AI
GFAI
$5.42M
| $263K | ﹤0.01% |
661,539
+51,475
| +8% | +$24.8K |
2024 Q4
6 quarters
|
|
6580
TCW Transform 500 ETF
VOTE
$1.08B
| $263K | ﹤0.01% |
2,986
+64
| +2% | +$5.46K |
2025 Q3
3 quarters
|
|
6581
Atrium Therapeutics
RNA
$143M
| $263K | ﹤0.01% |
19,572
-30,242
| -61% | -$395K |
2026 Q1
1 quarter
|
|
6582
Regencell Bioscience
RGC
$2.61B
| $263K | ﹤0.01% |
43,208
+19,323
| +81% | +$464K |
2025 Q2
4 quarters
|
|
6583
Invesco BulletShares 2031 High Yield Corporate Bond ETF
BSJV
$135M
| $263K | ﹤0.01% |
10,016
+2,844
| +40% | +$74.7K |
2026 Q1
1 quarter
|
|
6584
Sprott Lithium Miners ETF
LITP
$26.2M
| $263K | ﹤0.01% |
+21,041
| New | +$322K |
2026 Q2
0 quarters
|
|
6585
Neuropace
NPCE
$429M
| $263K | ﹤0.01% |
16,534
-11,269
| -41% | -$181K |
2024 Q1
9 quarters
|
|
6586
CALL
Universal Health Services
UHS
$11.5B
| $262K | ﹤0.01% |
+1,764
| New | +$287K |
2026 Q2
0 quarters
|
|
6587
FT Vest US Equity Enhance & Moderate Buffer ETF July
XJUL
$41.2M
| $262K | ﹤0.01% |
6,429
+5,873
| +1,056% | +$236K |
2025 Q1
5 quarters
|
|
6588
First Bank
FRBA
$488M
| $262K | ﹤0.01% |
14,754
+2,492
| +20% | +$40K |
2014 Q4
46 quarters
|
|
6589
iShares MSCI Norway ETF
ENOR
$322M
| $261K | ﹤0.01% |
+8,315
| New | +$301K |
2026 Q2
0 quarters
|
|
6590
Scilex Holding
SCLX
$12M
| $260K | ﹤0.01% |
33,376
+26,908
| +416% | +$197K |
2021 Q1
21 quarters
|
|
6591
Neuraxis
NRXS
$78.4M
| $260K | ﹤0.01% |
35,575
-9,767
| -22% | -$72.1K |
2025 Q4
2 quarters
|
|
6592
JPMorgan USD Emerging Markets Sovereign Bond ETF
JPMB
$96.5M
| $258K | ﹤0.01% |
6,407
+83
| +1% | +$3.32K |
2026 Q1
1 quarter
|
|
6593
TechTarget
TTGT
$190M
| $258K | ﹤0.01% |
71,575
-31,670
| -31% | -$145K |
2016 Q3
39 quarters
|
|
6594
Adicet Bio
ACET
$28.6M
| $258K | ﹤0.01% |
29,817
-8,551
| -22% | -$67.4K |
2023 Q2
12 quarters
|
|
6595
DB Gold Double Long ETN due February 15, 2038
DGP
$212M
| $257K | ﹤0.01% |
+1,973
| New | +$332K |
2026 Q2
0 quarters
|
|
6596
High-Trend International Group
HTCO
$15.9M
| $257K | ﹤0.01% |
60,976
+29,755
| +95% | +$210K |
2024 Q1
9 quarters
|
|
6597
Dimensional Inflation-Protected Securities ETF
DFIP
$1.13B
| $256K | ﹤0.01% |
6,212
+1,600
| +35% | +$67K |
2026 Q1
1 quarter
|
|
6598
Concrete Pumping Holdings
BBCP
$479M
| $256K | ﹤0.01% |
21,253
+11,279
| +113% | +$96.8K |
2019 Q1
29 quarters
|
|
6599
Barings Global Short Duration High Yield Fund
BGH
$255M
| $256K | ﹤0.01% |
18,163
+12,082
| +199% | +$170K |
2014 Q4
46 quarters
|
|
6600
Powerlaw Corp
PWRL
$477M
| $256K | ﹤0.01% |
+17,431
| New | +$326K |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.